Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Assets Average (2016 - 2025)

Historic Assets Average for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to $2.6 billion.

  • Ptc Therapeutics' Assets Average rose 4042.11% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 4042.11%. This contributed to the annual value of $1.8 billion for FY2024, which is 1.65% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Assets Average stood at $2.6 billion, which was up 4042.11% from $2.6 billion recorded in Q2 2025.
  • Ptc Therapeutics' Assets Average's 5-year high stood at $2.6 billion during Q2 2025, with a 5-year trough of $1.3 billion in Q3 2023.
  • Over the past 5 years, Ptc Therapeutics' median Assets Average value was $1.9 billion (recorded in 2024), while the average stood at $1.9 billion.
  • Per our database at Business Quant, Ptc Therapeutics' Assets Average crashed by 2314.62% in 2023 and then skyrocketed by 4467.2% in 2024.
  • Ptc Therapeutics' Assets Average (Quarter) stood at $2.0 billion in 2021, then dropped by 16.81% to $1.6 billion in 2022, then dropped by 3.85% to $1.6 billion in 2023, then grew by 12.41% to $1.8 billion in 2024, then soared by 48.79% to $2.6 billion in 2025.
  • Its last three reported values are $2.6 billion in Q3 2025, $2.6 billion for Q2 2025, and $2.2 billion during Q1 2025.